öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£º¸ß½¨
ÐÔ±ð£º
ÈËÆøÖ¸Êý£º243

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºÖÐÎ÷Ò½½áºÏÑо¿Ôº
Ö°³Æ£º
µ¼Ê¦ÀàÐÍ£º²©µ¼
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£º
Ñо¿ÁìÓò£º 1¡¢ÖÐÒ©·ÀÖÎÔàÆ÷ÏËά»¯¼°Æä·Ö×Ó»úÖÆÑо¿£»2¡¢ºôÎüÒ©Àíѧ£»3¡¢ÖÐÒ©¿¹ÏËά»¯»îÐÔɸѡ¼°Æäת»¯ÑÐ... [Õ¹¿ª]


Ñо¿ÁìÓò£º 1¡¢ÖÐÒ©·ÀÖÎÔàÆ÷ÏËά»¯¼°Æä·Ö×Ó»úÖÆÑо¿£»2¡¢ºôÎüÒ©Àíѧ£»3¡¢ÖÐÒ©¿¹ÏËά»¯»îÐÔɸѡ¼°Æäת»¯Ñо¿Ó뿪·¢¡£ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºgaojianayfy@163.com


¸öÈ˼òÊö :
¸ß½¨£¬1976Äê1ÔÂÉú£¬²©Ê¿¡¢Ö÷ÈÎҩʦ¡¢²©Ê¿Éúµ¼Ê¦¡£2009Äê±ÏÒµÓÚ°²»ÕÒ½¿Æ´óѧ£¬»ñҽѧ²©Ê¿Ñ§Î»¡£1998-2015Ä깤×÷ÓÚ°²»ÕÒ½¿Æ´óѧµÚÒ»¸½ÊôÒ½Ôº¡£ÏÖÈÎÖ°ÓÚ´óÁ¬Ò½¿Æ´óѧ¸½ÊôµÚ¶þÒ½Ôº¡£µ£ÈÎÖйúÒ©Àíѧ»á²¹ÒæÒ©Ò©ÀíöλÔÓéÀֵǼÈë¿ÚÏÂÔØίԱ»á³£ÎñίԱ¡¢ÖлªÖÐҽҩѧ»áÖƼÁ·Ö»á³£ÎñίԱ¡¢ÖÐÒ©ÅÚÖÆ·Ö»áºÍÖÐҩʵÑéÒ©Àí·Ö»áίԱ¡¢ÁÉÄþʡҽѧ»áÁÙ´²Ò©Ñ§·Ö»á³£ÎñίԱ£»¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîĿͬÐÐÆÀÒéר¼Ò£¬È«¹úÆÕͨ¸ßµÈҽѧԺУҩѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¡°Ê®ÈýÎ塱¹æ»®½Ì²Ä¡¶ÖÐҽҩѧ¸ÅÒª¡·¸±Ö÷±à¡¢¹ú¼ÒÎÀ¼Æί ¡°Ê®¶þÎ塱¹æ»®½Ì²Ä¡¶ÖÐÒ©ÅÚÖƹ¤³Ìѧ¡·¡¢¡¶ÖÐÒ½ÖÐҩѧ»ù´¡¡·±àί¡¢¡¶°²»ÕÒ½Ò©¡·ÔÓÖ¾³£Îñ±àίºÍÈ«¹úְҵԺУöλÔÓéÀֵǼÈë¿ÚÏÂÔؼ¼ÄÜ´óÈü ¡°ÖÐÒ©´«Í³¼¼ÄÜ´óÈü¡±ÈüÏî²ÃÅС£½üÎåÄêÒÔµÚÒ»»òͨѶ×÷ÕßÔÚPhytomedicine¡¢Journal of Ethnopharmacology¡¢The International Journal of Biochemistry & Cell BiologyºÍ Journal of Pharmacology and Experimental TherapeuticsµÈÆÚ¿¯·¢±íSCIÂÛÎÄ10ƪ£¬ÏȺóÖ÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿4Ïʡ²¿¼¶¿ÆÑÐÏîÄ¿6Ï»ñ¹ú¼Ò·¢Ã÷רÀû4ÏîºÍÖйúÒ©Àíѧ»áµÚÊ®Áù½ì¡°ÓÅÐãÇàÄêÒ©Àíѧ¹¤×÷Õß½±¡±µÈÈÙÓþ¡£¼æÈÎBritish Journal of Pharmacology¡¢Phytomedicine¡¢Journal of Pharmacology and Experimental Therapeutics¡¢Journal of Cellular and Molecular Medicine¡¢ÖйúÒ©Àíѧͨ±¨¡¢ÖйúÁÙ´²Ò©ÀíѧÓëÖÎÁÆѧ¡¢ÖйúҽԺҩѧÔÓÖ¾¡¢ÖгÉÒ©µÈѧÊõÆÚ¿¯Éó¸åר¼Ò¡£

¿ÆÑй¤×÷ :
ÔÚÑÐÏîÄ¿1. P62½éµ¼µÄKeap1-Nrf2-ARE;¾¶ÔÚ·ÎÏËά»¯½ø³ÌÖÐ×÷Óü°Æäµ÷¿Ø»úÖÆ£¨**£©£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬2015.1-2018.12£¬70ÍòÔª£¬Ö÷³Ö¡£2. Nrf2½éµ¼µÄTGF¦Â-SMADͨ·ÔÚÑõ»¯Ó¦¼¤Ö·ÎÏËά»¯ÖеÄ×÷Óü°µ±¹é²¹Ñª×ÜÜյĵ÷¿Ø»úÖÆ£¬£¨**£©¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÃæÉÏÏîÄ¿£¬2013.1-2016.12£¬90ÍòÔª£¬Ö÷³Ö¡£
´ú±íÎÄÕÂ
1£®Total glucosides of Danggui¨CBuxue¨CTang attenuatesbleomycin-induced pulmonary fibrosis via inhibition of extracellular matrix remodeling. Journal of Pharmacy and Pharmacology . 2012 £¬64(6):811-820. (IF:2.264).£¨Í¨Ñ¶×÷Õߣ©2.Antifibrosis effects of total glucosides of Danggui¨CBuxue¨CTang in a rat model of bleomycin-induced pulmonary fibrosis. Journal of Ethnopharmacology. 2011£¬136£¨1£©£º21-26.£¨IF:2.998£©. £¨µÚÒ»×÷Õߣ©3.Total Polysaccharide of Yupingfeng Protects against Bleomycin-Induced Pulmonary Fibrosis via Inhibiting TGF-?1-Mediated Type I Collagen Abnormal Deposition in Rats. Journal of Pharmacy and Pharmacology, 2014 £¬66(12):1786-95 (IF:2.264).£¨Í¨Ñ¶×÷Õߣ©4. Emerging role of HMGB1 in fibrotic diseases. Journal of Cellular and Molecular Medicine., 2014 £¬18(12):2331-9.£¨IF:4.014£©.£¨Í¨Ñ¶×÷Õߣ©